Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
11.968 / 17.034
#95738

Re: Farmas USA

IBB

Yo apostaría por el toque en el 240 cerca de las elecciones y dependiendo de quién gane cielo o infierno a corto plazo. También una subida ahora caza incautos para hacer un triple suelo a corto plazo. Después del palo que llevo en las Nvax me da miedo mirar ese gráfico y sabiendo acontecimientos cercanos mis pronósticos no son alentadores. Jajaja Además la Clinton sale mucho en la Tv ahora, hay que ir con pies de plomo porque en cualquier momento suelta una perla y te encienden vivo.

#95739

Re: Farmas USA

hznp

http://ih.advfn.com/p.php?pid=nmona&article=72658003&adw=1126416

As previously announced in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on September 12, 2016, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Misneach Corporation, a Delaware corporation and our indirect wholly owned subsidiary (“Purchaser”), and Raptor Pharmaceutical Corp., a Delaware corporation (“Raptor”). On September 26, 2016, pursuant to the terms of the Merger Agreement, Purchaser commenced a tender offer to purchase all of the issued and outstanding shares of Raptor common stock for $9.00 per share in cash (the “Offer”). If successful, the Offer will be followed by a merger of Purchaser with and into Raptor, with Raptor surviving as our indirect wholly owned subsidiary (together with the Offer, the “Transactions”).

http://ih.advfn.com/p.php?pid=nmona&article=72657748&adw=1126416

Horizon Pharma plc (Nasdaq:HZNP) (“Horizon”), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Horizon Pharma, Inc. and Horizon Pharma USA, Inc., its wholly owned subsidiaries, intend, subject to market and other considerations, to offer $300 million aggregate principal amount of senior notes due 2024, and to borrow $375 million aggregate principal amount of incremental term loans under Horizon’s existing senior secured credit facility.

Horizon currently expects to use the net proceeds from the offering of notes and the incremental term loans to fund a portion of Horizon’s planned acquisition of Raptor Pharmaceutical Corp. (“Raptor”), repay Raptor’s outstanding debt, and pay any prepayment premiums, fees and expenses in connection with the foregoing.

#95740

Re: Farmas USA

IBB
Pues sería un -11% añadido en 3 semanas, aunque a este ritmo la semana que viene.
Esperemos que no. O al menos haya algún rebote importante estos días.

#95743

Re: Farmas USA

El precedente de la FDA con SRTP -> otras empiezan a apelar decisiones. Empieza BMRN alegando que sus datos son mejores que los de SRTP.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#95744

Re: Farmas USA

Lo siento acabo de leerte y ya he visto lo que es, no es malo, me atrevería a decir que incluso positivo.
No obstante no sabia por donde irían los tiros. no quería ni hacer conjeturas.

TGTX